<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xmlns:video="http://www.google.com/schemas/sitemap-video/1.1"
        xmlns:xhtml="http://www.w3.org/1999/xhtml">
  <url>
    <loc>https://global.investnews.co.kr/news/apollon-series-a-funding-non-invasive-cgm</loc>
    <lastmod>2026-10-01T15:14:36+09:00</lastmod>
    <xhtml:link rel="alternate" hreflang="en" href="https://global.investnews.co.kr/news/apollon-series-a-funding-non-invasive-cgm"/>
    <xhtml:link rel="alternate" hreflang="ja" href="https://global.investnews.co.kr/ja/news/apollon-series-a-funding-non-invasive-cgm"/>
    <xhtml:link rel="alternate" hreflang="vi" href="https://global.investnews.co.kr/vi/news/apollon-series-a-funding-non-invasive-cgm"/>
    <xhtml:link rel="alternate" hreflang="zh" href="https://global.investnews.co.kr/zh/news/apollon-series-a-funding-non-invasive-cgm"/>
    <xhtml:link rel="alternate" hreflang="x-default" href="https://global.investnews.co.kr/news/apollon-series-a-funding-non-invasive-cgm"/>
    <news:news>
      <news:publication>
        <news:name>INVEST NEWS</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-01T15:14:36+09:00</news:publication_date>
      <news:title><![CDATA[[Series] Non-invasive CGM Startup Apollon Secures 5 billion won... To be Invested in US Clinical Trials and FDA Approval]]></news:title>
      <news:keywords><![CDATA[Apollon, CGM, SBI Investment, Daewoong, Naver, Joslin Diabetes Center, FDA, MOGLU]]></news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://global.investnews.co.kr/storage/investnews-global/2026/10/cd5b75ee-1d3f-42d5-ad3f-7ff5dcb198d9-e07e62ae-og.webp</image:loc>
      <image:caption><![CDATA[Medical device startup Apollon, which develops needle-free continuous glucose monitors (CGM), has announced it secured 5 billion won in Series A funding. The funds will be used for clinical studies at the Joslin Diabetes Center and preparing for FDA De Novo authorization.]]></image:caption>
      <image:title><![CDATA[[Series] Non-invasive CGM Startup Apollon Secures 5 billion won... To be Invested in US Clinical Trials and FDA Approval]]></image:title>
    </image:image>
  </url>
  <url>
    <loc>https://global.investnews.co.kr/news/lee-hoon-ki-stock-price-suppression-prevention-act-press-conference</loc>
    <lastmod>2026-09-30T17:53:18+09:00</lastmod>
    <xhtml:link rel="alternate" hreflang="en" href="https://global.investnews.co.kr/news/lee-hoon-ki-stock-price-suppression-prevention-act-press-conference"/>
    <xhtml:link rel="alternate" hreflang="ja" href="https://global.investnews.co.kr/ja/news/lee-hoon-ki-stock-price-suppression-prevention-act-press-conference"/>
    <xhtml:link rel="alternate" hreflang="vi" href="https://global.investnews.co.kr/vi/news/lee-hoon-ki-stock-price-suppression-prevention-act-press-conference"/>
    <xhtml:link rel="alternate" hreflang="zh" href="https://global.investnews.co.kr/zh/news/lee-hoon-ki-stock-price-suppression-prevention-act-press-conference"/>
    <xhtml:link rel="alternate" hreflang="x-default" href="https://global.investnews.co.kr/news/lee-hoon-ki-stock-price-suppression-prevention-act-press-conference"/>
    <news:news>
      <news:publication>
        <news:name>INVEST NEWS</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-30T17:53:18+09:00</news:publication_date>
      <news:title><![CDATA[Lee Hoon-ki: "Even deviating from criteria for just two half-years avoids low PBR estimation"... Criticizes government's stock price suppression plan]]></news:title>
      <news:keywords><![CDATA[Lee Hoon-ki, Democratic Party of Korea, Stock Price Suppression Prevention Act, VIP Asset Management, Align Partners Capital Management, Quad Asset Management, National Assembly of the Republic of Korea, Inheritance Tax and Gift Tax Act]]></news:keywords>
    </news:news>
    <image:image>
      <image:loc>https://global.investnews.co.kr/storage/investnews-global/2026/09/8032c742-a769-4384-b416-747a93b12065-6e91879c-og.webp</image:loc>
      <image:caption><![CDATA[Democratic Party of Korea lawmaker Lee Hoon-ki and representatives from institutional investors held a press conference to urge the passage of the Stock Price Suppression Prevention Act, criticizing the government's current proposal for being too easy to circumvent.]]></image:caption>
      <image:title><![CDATA[Lee Hoon-ki: "Even deviating from criteria for just two half-years avoids low PBR estimation"... Criticizes government's stock price suppression plan]]></image:title>
    </image:image>
  </url>
</urlset>
